HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CGS 27023A

a matrix metalloproteinase inhibitor
Also Known As:
CGS-27023A; MMI 270B; MMI-270B; MMI270; MMI270B; N-hydroxy-2(R)-((4-methoxysulfonyl)(3-picolyl)amino)-3-methylbutaneamide hydrochloride
Networked: 13 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nakajima, Motowo: 3 articles (01/2008 - 06/2004)
2. Okada, Mikiko: 2 articles (01/2008 - 07/2003)
3. Choi, L: 2 articles (01/2005 - 07/2001)
4. Saiki, Ikuo: 2 articles (01/2004 - 01/2003)
5. Nakamura, Eliane Shizuka: 2 articles (01/2004 - 01/2003)
6. Koizumi, Keiichi: 2 articles (01/2004 - 01/2003)
7. Nakajima, M: 2 articles (07/2001 - 07/2000)
8. Kasaoka, Tatsuhiko: 1 article (01/2008)
9. Nishiyama, Hiroko: 1 article (01/2008)
10. Sasatomi, Teruo: 1 article (01/2006)

Related Diseases

1. Neoplasm Metastasis (Metastasis)
2. Neoplasms (Cancer)
3. Lung Neoplasms (Lung Cancer)
4. Colonic Neoplasms (Colon Cancer)
5. Brain Edema (Cerebral Edema)

Related Drugs and Biologics

1. Matrix Metalloproteinase 14 (MT1-MMP)
2. Matrix Metalloproteinases
3. Tissue Inhibitor of Metalloproteinase-2
4. Tissue Inhibitor of Metalloproteinase-1
5. Proliferating Cell Nuclear Antigen (PCNA)
6. Proteoglycans (Proteoglycan)
7. Edetic Acid (EDTA)

Related Therapies and Procedures

1. Lymph Node Excision (Lymph Node Dissection)
2. Oral Administration